FMC reported revenue of $1.34 billion in the first quarter of 2023, with record year-over-year growth in North America
FMC recently reported first-quarter 2023 revenue of $1.34 billion, which was flat compared to the first quarter of 2022, with growth of 4%. The earnings report includes analysis of 2023 first quarter earnings, and full year 2023 earnings forecast, the details are as follows.
Highlights in the first quarter of 2023
Revenue was $1.34 billion, flat from the first quarter of 2022 and up 4% organically
Consolidated GAAP net income was $196 million, down 7% from the first quarter of 2022
Adjusted EBITDA was $362 million, up 2% from the first quarter of 2022
Consolidated GAAP diluted earnings per share were $1.55, down 6% from the first quarter of 2022
Annual Forecast in 2023
Revenue guidance was maintained at $608 billion to $6.22 billion, up 6 % from the 2022 midpoint
Raised its adjusted EBITDA forecast to $150 billion to $1.56 billion, a median 9% increase from 2022
Raised its adjusted diluted earnings per share forecast to $7.34 to $7.94, reflecting a median increase of 3% compared to 2022, excluding any impact from potential additional share repurchases in 2023
FMC reported revenue of $1.34 billion for the first quarter of 2023, unchanged from the first quarter of 2022 and up 4% organically. On a GAAP basis, earnings per diluted share for the first quarter were $1.55, down 6% from the first quarter of 2022. Adjusted earnings per diluted share for the first quarter were $1.77, down 6% from the first quarter of 2022. Adjusted earnings, however, were $0.02 higher than the median of the guidance range.
Mark Douglas, President and Chief Executive Officer, commented, "FMC delivered solid results in the first quarter with strong pricing, rapid introduction of new products, and cost control driving margin growth. New product additions and expanded market access contributed to strong sales growth in North America, helping to offset sales headwinds elsewhere."
In Latin America, revenue fell 12% from the first quarter of 2022 as drought reduced pesticide application in southern Brazil and Argentina. Sales in Mexico and the Andean region remained stable. Sales in Asia fell 22% from a year earlier as dry weather in Australia and aggressive inventory management in India impacted revenues.
On a global basis, the company's plant Health segment revenue for the quarter decreased 2%, mainly due to strong sales growth in EMEA and Latin America, driven by foreign exchange and a decrease in North American sales volume following strong growth in the fourth quarter.
FMC's adjusted EBITDA for the first quarter was $362 million, up 2% from the same period last year, and EBITDA margin increased by more than 60 points from the same period last year. This was primarily due to pricing increases, new product launches and cost controls, partially offset by the continued impact of foreign exchange.
Annual forecast
Full-year 2023 revenue is forecast to be between $6.08 billion and $6.22 billion, unchanged from its last guidance range and up 6% from the mid-point in 2022. FMC raised its full-year adjusted EBITDA guidance by $10m. Full-year adjusted EBITDA is expected to be in the range of $1.5 billion to $1.56 billion, an increase of 9% year-over-year based on first quarter results, continued price increases, an aggressive product mix and projected input costs. The 2023 adjusted diluted earnings per share range also increased to $7.34 to $7.94, representing a median year-over-year increase of 3%. FMC maintained its full-year free cash flow guidance of between $530m and $720m.
We expected that the second-quarter results to be broadly in line with last year. Based on the first quarter results and our expectations for pricing gains, the mix of new products and input cost benefits that are expected to materialise in the second half, particularly in the third quarter, we are raising our full-year EBITDA guidance and narrowing the range. The strength of our product mix, the diversity of our crop mix, and our investments in market access are well positioned for revenue growth and margin improvement in the coming year."
2026-08-08
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Renaissance BioScience Receives Genome BC Funding to Extend RNAi Biopesticide Platform to Target Soil-Dwelling Crop Pests
-
The Crop Protection Patent Cliff Is Here
-
The project with an investment of ¥105 million and an annual output of 4000 tons of Propargite is to be built
-
Brazil's Agriconnection uses a new model to import and direct sell pesticides, with revenue exceeding $340 million
-
The Indian biopesticide market will grow at a CAGR of 9.38%
-
China's insecticide import and export data for June
-
Jiangsu TrustChem’s degradable pesticide packaging bottle won the domestic and international invention patent authorization
-
FMC launches a new herbicide (Tetflupyrolimet), marking a new milestone in the herbicide market
-
Hebang Biological intends to increase its stake in Australian listed company AEV and achieve control
-
The operating rate of Brazil's chemical industry has deteriorated: at just 58%, the latest figure is the lowest since 1990
Recommend Reading
-
Jotun and CSSC South China Partner on Offshore & Industrial Coatings
-
Saudi Arabia Flips the Switch on Jafurah: World’s Largest Non-U.S. Shale Gas Field Begins Production
-
Covestro Acquires HDI Sites in US and Thailand to Expand Footprint
-
India Loosens Import Leash: Scraps Quality Control Orders for 7 Key Petrochemicals to Revive Manufacturing
-
Lanxess Closes Plants as Q2 Profit Slumps, Lowers Outlook
-
Butadiene rubber prices fall back to pre-Middle East conflict levels in China
-
Fundamentals Lack Positive Factors, PTA Prices Fluctuate and Weaken
-
Weekly Caustic Soda Price Consolidation Trend (6.22-6.26) in China
-
Market Momentum Slows Down; Early September ABS Prices Likely to Decline at Lower Levels
-
This week, the styrene market in China showed a weak decline (6.22-6.26)